FLNA

Filana Therapeutics, Inc.

Investor Moves

NameValueActionChangePriceCurrent Price
Ken GriffinCitadel Advisors
$-937.9K
ExitQ1 2026
$938k
--
$1.50
Steven CohenPoint72
$66k39.1k shares
TrimQ1 2026
$527k
$1.69
$1.50
Ken GriffinCitadel Advisors
$938k473.7k shares
ExitQ4 2025
$1.4M
$1.98
$1.50
Ken GriffinCitadel Advisors
$938k473.7k shares
TrimQ4 2025
$460k
$1.98
$1.50
Ken GriffinCitadel Advisors
$954.1K
AddQ3 2025
$954k
--
$1.50
Ken GriffinCitadel Advisors
$954.1K
AddQ3 2025
$954k
--
$1.50

News

globenewswire.comFilana Therapeutics Reports Q1 2026 Financial Results and Business Updateglobenewswire.comMay 7globenewswire.comFilana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIIIglobenewswire.comMay 5defenseworld.netZevra Therapeutics (NASDAQ:ZVRA) versus Cassava Sciences (NASDAQ:FLNA) Head-To-Head Contrastdefenseworld.netApr 27